Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Judge slashes $8 billion Risperdal award against Johnson & Johnson to $6.8 million
(Reuters) - A Pennsylvania judge on Friday slashed to $6.
Celltrion to build plant in China
SEOUL, Jan.
This AI can detect low blood sugar from ECG readings
A team of researchers from the University of Warwick have built an artificial intelligence they say can detect hyoglycaemic events — drops in blood sugar that can pose a real threat to those with or...
VALTOCO is approved by FDA
SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc.
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
SHANGHAI and LEVERKUSEN, Germany, January 16, 2020 –WuXi Biologics (“WuXi Bio”) (2269.
German drug assessment body not convinced by Bayer's cancer drug Vitrakvi
FRANKFURT (Reuters) - Germany’s drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence of benefits, in a setback to...
Nektar withdraws application for opioid painkiller after FDA panel's vote
(Reuters) - Nektar Therapeutics said on Tuesday it was withdrawing the application for its opioid painkiller for adults with chronic low back pain, after a U.
Here's Why Rigel Pharmaceuticals Is Erupting This Week
The pharmaceutical stock is surging after providing preliminary results for the fourth quarter of 2019.
Horizon enlists Mammoth in CRISPR move
Horizon Discovery has announced a new collaboration and license agreement with Mammoth Biosciences, in order to access the company’s novel CRISPR platform and facilitate a new generation of genetica...
Cyber attacks hit more than half of healthcare orgs in last year
A new report has revealed that last year in the UK, 67% of healthcare organisations experienced a cyber security incident.
UK cell and gene clinical trials up 45% from 2018
The Cell and Gene Therapy Catapult (CGT Catapult) has revealed that there are currently 127 ongoing cell and gene trials in the UK, representing a ~45% increase compared to 2018, and accou...
Swinging for the Fences: Alexion to Test Ultomiris in ALS
Alexion Pharmaceuticals announced at the JP Morgan Healthcare Conference that it was planning to initiate a pivotal Phase III trial of Ultomiris (ravulizumab) in amyotrophic lateral sclerosis ...
331
332
333
334
335
336
337
338
339
